Targeting Interleukin-6 Signaling with Tocilizumab in Atherosclerosis: A Meta-Analysis of Anti-Inflammatory Effects and Plaque Stabilization. OAIJMR. 2025;5(1):1-14. doi:10.37275/oaijmr.v5i1.686